Paper Details
- Home
- Paper Details
Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats.
Author: AsfahaS, ChapmanK, Del SoldatoP, FiorucciS, McKnightW, MorelliA, MuscaráM N, VergnolleN, WallaceJ L
Original Abstract of the Article :
BACKGROUND & AIMS: Nitric oxide (NO)-releasing derivatives of cyclooxygenase inhibitors exhibit enhanced anti-inflammatory activity and greatly reduced gastrointestinal toxicity. We evaluated whether a similar derivatization of mesalamine (5-aminosalicylic acid) would improve its anti-inflammatory a...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/s0016-5085(99)70448-8
データ提供:米国国立医学図書館(NLM)
Boosting Mesalamine's Power: Nitric Oxide for Inflammation Relief
This research investigates the potential of nitric oxide (NO)-releasing derivatives of mesalamine, a drug used to treat inflammatory bowel disease (IBD), to enhance its anti-inflammatory activity. The study explores the effects of an NO-releasing derivative of mesalamine (NCX-456) in a rat model of colitis.
Nitric Oxide: A Potential Game Changer for IBD
The study found that the NO-releasing derivative of mesalamine was significantly more effective than mesalamine alone in reducing colitis severity, indicating that the addition of NO may enhance the drug's anti-inflammatory effects. These findings suggest that NO-releasing derivatives of mesalamine may offer a promising new approach to treating IBD.
Fighting Inflammation: A Desert Oasis for Gut Health
Imagine a desert traveler suffering from a severe sandstorm, a metaphor for the inflammation and discomfort experienced by those with IBD. This research explores the potential of nitric oxide to calm the storm, providing relief and promoting gut health. This study offers hope for a new approach to treating IBD and alleviating the suffering caused by this debilitating disease.
Dr.Camel's Conclusion
This research highlights the potential of NO-releasing derivatives of mesalamine to enhance anti-inflammatory activity and offers a promising new avenue for treating IBD. Like a desert oasis providing relief from the heat, this innovative approach could offer a much-needed respite for those suffering from chronic inflammation in their gut.
Date :
- Date Completed 1999-09-16
- Date Revised 2019-07-07
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.